NIAID has made groundbreaking contributions to the field of hepatitis research. NIAID scientists discovered the hepatitis A and E viruses; developed one of the first diagnostic tests for hepatitis A; and were instrumental in the creation of the hepatitis A vaccine, which is recommended by the Centers for Disease Control and Prevention of all children over 1 year old. Today, NIAID continues its leadership by conducting and supporting research to better understand the development of hepatitis diseases and their effect on the immune system and to develop novel treatments and vaccines against diseases caused by hepatitis viruses.
The Path to a Cure for Hepatitis C in People with HIV—July 27, 2015
NIH-Led Study to Assess Community-Based Hepatitis C Treatment in Washington, D.C.—March 6, 2015
Media Availability: High Hepatitis C Cure Rate Seen in NIH-Led Trial of Six-Week Oral Drug Regimens—Jan. 12, 2015
NIH Study Describes Burden of Hepatitis C in India—Dec. 4, 2014
All Hepatitis News Releases
Last Updated July 27, 2015